---
document_datetime: 2023-09-21 19:13:47
document_pages: 17
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/infanrix-penta-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: infanrix-penta-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 10.9125156
conversion_datetime: 2025-12-20 14:00:54.345762
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Infanrix penta

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                                                                                                                              | Opinion/ Notification 1 issued on no   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------|---------------------------------------------|----------------------------------|-----------|
| WS/0401              | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate product | 25/07/2013                             | n/a                                         |                                  |           |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

United Kingdom Medical product no longer authorised

<!-- image -->

<div style=\"page-break-after: always\"></div>

| WS/0392   | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. To replace the current FHA reference standard with a new lot. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                             | 27/06/2013   | n/a                       |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|---------------------------|
| IG/0306   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                       | 12/06/2013   | n/a longer                |
| WS/0384   | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. To introduce a new working seed lot used for the manufacturing process of the acellular pertussis (Pa) antigens. B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological medicinal product and is not related to a protocol |              | 30/05/2013 n/a product no |
| IG/0299   | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                   | 26/04/2013   | n/a                       |

<div style=\"page-break-after: always\"></div>

| IG/0297   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                | 19/04/2013    | n/a            |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------|----------------|
| II/0086   | Replacement of the current screwcaps used for the purified bulk transfer and storage. B.I.c.1.b - Change in immediate packaging of the AS - Qualitative and/or quantitative composition for sterile and non-frozen biological/immunological ASs                                                                                               | 21/02/2013    | n/a authorised |
| WS/0336   | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. To introduce a new method for monitoring homogeneity during filling. B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation | 17/01/2013 no | n/a longer     |
| WS/0340   | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. Change of specifications of reagent. B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation product                | 17/01/2013    | n/a            |

<div style=\"page-break-after: always\"></div>

| WS/0239   | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. Registration of an additional site for QC sterility testing activities for pre-filled syringes, following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. The batch release site remains unchanged. B.II.b.2.a - Change to batch release arrangements and quality control testing of the FP - Replacement or addition of a site where batch control/testing takes place                                                                                                                                                                                                                       | 19/04/2012   | n/a           |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|---------------|
| WS/0201/G | This was an application for a group of variations following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. To propose new target fill volume controls. To align the volume specifications to be applied at release and during stability evaluation. To revise QC release procedures for final container volume determination. B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation B.II.b.3.b - Change in the manufacturing process of the finished product - Substantial changes to a manufacturing process that may have a significant impact on the quality, safety and efficacy of the medicinal product B.II.d.2.a - Change in test procedure for the finished Medical product | 19/01/2012   | n/a no longer |

<div style=\"page-break-after: always\"></div>

|           | product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                 | authorised                                                                                                                                                                                                                                                                                        |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| WS/0166   | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. Registration of an additional facility for filling of finished product. The change relates to pre-filled syringes only. B.II.b.1.c - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for biological/immunological medicinal products. | 20/10/2011                      | 20/10/2011                                                                                                                                                                                                                                                                                        |
| WS/0113   | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. Changes to the manufacturing process of the FHA and PRN acellular pertussis antigens. B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological medicinal product and is not related to a protocol product                                                                    | 19/05/2011 19/05/2011 no longer |                                                                                                                                                                                                                                                                                                   |
| IG/0064/G | This was an application for a group of variations. Update of section 4.8 of the SmPC to include immediate injection site pain, stinging and burning sensation. The PL is updated in accordance. The MAH Medical                                                                                                                                                                                                                                                                                                      | 04/05/2011 n/a                  | Following clusters of spontaneous reports of immediate onset injection site pain reported in certain batches of the preservative-free formulation of Twinrix Adult, immediate pain, stinging and burning at the injection site has been reflected in section 4.8 of the SmPC and section 4 of the |

<div style=\"page-break-after: always\"></div>

|           | has also taken the opportunity to align section 4.6 of the prefilled syringe presentation with the vial presentation. Furthermore, the Labelling is updated to specify the container 'prefilled syringe'. In addition, the MAH has taken the opportunity to update the list of local representatives in the PL. B.II.e.2.a - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Tightening of specification limits B.II.e.2.b - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Addition of a new specification parameter to the specification with its corresponding test method B.II.e.3.a - Change in test procedure for the immediate packaging of the finished product - Minor changes to an approved test procedure B.II.e.3.c - Change in test procedure for the immediate packaging of the finished product - Deletion of a test procedure if an alternative test procedure is already authorised B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information product   | no longer   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------|
| IG/0052/G | B.II.e.7.a - Change in supplier of packaging components or devices (when mentioned in the dossier) - Deletion of a supplier This was an application for a group of variations. B.II.e.2.a - Change in the specification parameters Medical                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 18/03/2011  |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|         | and/or limits of the immediate packaging of the finished product - Tightening of specification limits B.II.e.2.b - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Addition of a new specification parameter to the specification with its corresponding test method B.II.e.2.c - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter)   |                          |                                  | authorised                                                                                                                                                                                                                                          |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------|----------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0072 | A change in the manufacturing process for Pertussis toxoid. B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological medicinal product and is not related to a protocol                                                                                                                                                                                                                                                                                      | 16/12/2010 21/12/2010 no | longer                           |                                                                                                                                                                                                                                                     |
| II/0068 | Changes to the manufacturing process of the diphteria drug substance. B.I.a.2.c - Changes in the manufacturing process of the AS - The change refers to a [-] substance in the manufacture of a biological/immunological medicinal product and is not related to a protocol Medical product                                                                                                                                                                                                                                                            | 21/10/2010 29/10/2010    |                                  |                                                                                                                                                                                                                                                     |
| R/0067  | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 24/06/2010 31/08/2010    | SmPC, Annex II, Labelling and PL | Based on the review of the available information the CHMP is of the opinion that the quality, the safety and the efficacy of Infanrix penta continues to be adequately and sufficiently demonstrated and considers that the benefit/risk profile of |

<div style=\"page-break-after: always\"></div>

|         |                                                                                                                                                                                                                                                                                                                               |               |            | Infanrix penta continues to be favourable. The CHMP therefore recommended that a renewal can be granted for unlimited validity. With this procedure the MAH also updated the product information (PI) to be in line with the current QRD requirements, to reflect the results of the user testing and to revise the contact details for Denmark and Cyprus. authorised   |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------|------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0069 | Change in a test procedure for the master and working seeds of Clostridium tetani and Corynebacterium dipheriae. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate | 11/08/2010    | n/a        | longer                                                                                                                                                                                                                                                                                                                                                                   |
| IB/0071 | Change in an in-process test for the active substance. B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation                                                                                                                                                            | 11/08/2010 no | n/a        |                                                                                                                                                                                                                                                                                                                                                                          |
| IA/0070 | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure product                                                                                                                                                                                                          | 04/08/2010    | n/a        |                                                                                                                                                                                                                                                                                                                                                                          |
| WS/0001 | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. To register an additional building for formulation activities.                                                                                                                  | 22/04/2010    | 22/04/2010 |                                                                                                                                                                                                                                                                                                                                                                          |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|         | B.II.b.1.c - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for biological/immunological medicinal products.   | authorised               |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------|
| II/0066 | Change in cell identity method. Change to the test procedure and/or specification of a raw material                                                                                                                                              | 17/12/2009 08/01/2010    |
| IB/0065 | IB_12_a_Change in spec. of active subst./agent used in manuf. of active subst. - tightening                                                                                                                                                      | 18/09/2009 n/a           |
| IB/0064 | IB_12_b_02_Change in spec. of active subst./agent in manuf. of active subst. - test parameter                                                                                                                                                    | 20/07/2009 n/a longer    |
| II/0062 | Introduction of new filter equipment during the manufacturing process of tetanus toxoid. Change(s) to the test method(s) and/or specifications for the active substance                                                                          | 25/06/2009 06/07/2009 no |
| II/0063 | Change to the primary pack stopper and tip cap for pre-filled syringes. Change(s) to the manufacturing process for the finished product product                                                                                                  | 25/06/2009 06/07/2009    |
| II/0057 | Change to the purification process of diphteria (D) and tetanus (T) toxoid. Change(s) to the manufacturing process for the active substance Medical                                                                                              | 19/03/2009 24/03/2009    |

<div style=\"page-break-after: always\"></div>

| II/0058   | Modification of the purification process for tetanus toxoid. Change(s) to the manufacturing process for the active substance                                                                                                                                                                                                                                                                                                                                                                                 | 19/03/2009   | 24/03/2009   | authorised                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0059   | Changes to raw materials used in the manufacturing process of the Inactivated Polio Virus antigens. Change to the test procedure and/or specification of a raw material                                                                                                                                                                                                                                                                                                                                      | 19/02/2009   | 04/03/2009   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| IB/0060   | IB_20_c_Change in test procedure for an excipient - other changes                                                                                                                                                                                                                                                                                                                                                                                                                                            | 11/02/2009   | n/a longer   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| IA/0061   | IA_05_Change in the name and/or address of a manufacturer of the finished product                                                                                                                                                                                                                                                                                                                                                                                                                            | 05/02/2009   | n/a no       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| IB/0056   | IB_25_a_02_Change to comply with Ph. - compliance with EU Ph. - excipient                                                                                                                                                                                                                                                                                                                                                                                                                                    | 23/12/2008   | n/a          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| IA/0055   | IA_25_b_01_Change to comply with Ph. - compliance with EU Ph. update - active substance                                                                                                                                                                                                                                                                                                                                                                                                                      | 18/11/2008   | n/a          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| II/0049   | Update of sections 4.2, 4.4, 4.5, 4.8 and 5.1 of the SPC based on a review of data available from clinical studies or post-marketing surveillance and in line with relevant guidelines. The PL was updated accordingly. In addition, the previously agreed class wording on apnoea was reflected in the PL as requested by the CHMP in July 2008. The MAH also took the opportunity to update all annexes (including labelling and annex II) in line with the latest version of the EMEA/QRD Medical product | 25/09/2008   | 30/10/2008   | Based on data from clinical trials and post marketing setting the product information was updated in order to clarify the prescribing information and extend the advice provided to the health care provider. The undesirable effects section was fully reorganised in accordance with the frequency and seriousness of the events that have been reported. This means that some events were moved, reworded or deleted if not applicable. Apnoea was added as reported in the post marketing setting, in line with |

<div style=\"page-break-after: always\"></div>

|         | templates and to update the contact details of some local representatives in the PL (Romania, Slovakia). Update of Summary of Product Characteristics, Labelling and Package Leaflet                                                                                                             |               | longer                 | the warning which had been added following a variation that affected all infant vaccines. Further to the SPC update regarding the potential risk of apnoea in very premature infants, the PL was updated to inform that in babies born very prematurely (at or before 28 weeks of gestation) longer gaps than normal between breaths may occur for 2-3 days after vaccination. Wording on persistence of protective antibodies against Hepatitis B was included in the product information. All annexes (SPC, annex II, labelling and PL) were updated in line with the latest version of the EMEA/QRD templates. The contact details for Romania and Slovakia were updated. authorised   |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------|------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0050 | Update of section 5.1 of the SPC with information from a pertussis vaccine surveillance and effectiveness study in Sweden. The MAH also took the opportunity to update the contact details of a local representative in the PL. Update of Summary of Product Characteristics and Package Leaflet | 26/06/2008 no | 13/08/2008 SmPC and PL | The effectiveness of several acellular pertussis-based combined vaccines was assessed via a long-term surveillance study in Sweden. Results over eight years of follow-up (1997-2005) showed that acellular pertussis vaccines are effective in infants vaccinated according to the 3-5-12 month vaccination schedule (i.e. primary vaccination at 3 and 5 months, booster dose at 12 months). However, protection against pertussis may be waning at 7-8 years of age with. Therefore, a second booster dose of pertussis vaccine may be needed in children aged 5-7 years who have previously been vaccinated according to this schedule.                                               |
| II/0051 | Update of section 4.2 of the SPC to harmonise the information on booster vaccination with that of Infanrix hexa. The PL was consequentially updated. Update of Summary of Product Characteristics and Package Leaflet Medical product                                                            | 26/06/2008    | 13/08/2008 SmPC and PL | Infanrix penta and Infanrix hexa are both indicated for primary and booster vaccination of infants. The primary vaccination schedule consists of three doses (such as 2, 3, 4 months; 3, 4, 5 months; 2, 4, 6 months) with an interval of at least one month between doses. Alternatively two doses may be administered in a schedule such as 3 and 5 months. Booster vaccination after the three-dose primary schedule should be administered at least 6 months after the last dose in the primary course and preferably before 18 months of                                                                                                                                             |

<div style=\"page-break-after: always\"></div>

|         |                                                                                                                                                                                                                                                    |               |                   | age. After primary vaccination with two doses a booster dose should be given at least 6 months after the last primary dose and preferably between 11 and 13 months of age. These recommendations have now been clarified in the SPC for Infanrix penta in order to be in line with that of Infanrix hexa. authorised                                                                                                                                                                                                                                                                                                                                                |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------|-------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0054 | IA_12_a_Change in spec. of active subst./agent used in manuf. of active subst. - tightening of spec.                                                                                                                                               | 07/07/2008    | n/a               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| II/0047 | Change(s) to the manufacturing process for the active substance                                                                                                                                                                                    | 30/05/2008    | 05/06/2008        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| II/0052 | Change(s) to the test method(s) and/or specifications for the finished product                                                                                                                                                                     | 24/04/2008    | 05/05/2008 longer |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| II/0053 | Change(s) to the test method(s) and/or specifications for the active substance                                                                                                                                                                     | 24/04/2008    | 05/05/2008        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| II/0048 | Update of sections 4.4 and 4.8 of the SPC to implement the class labelling text on the risk of apnoea following vaccination of very prematurely born infants agreed by the CHMP in July 2007. Update of Summary of Product Characteristics product | 15/11/2007 no | 18/12/2007 SmPC   | Following a review on the risk of apnoea in very premature infants after immunisation the CHMP recommended a class labelling on apnoea for all vaccines in very premature infants. The SPC was updated to include information about the potential risk of apnoea and the need for respiratory monitoring for 48-72h, when the primary immunisation series is administered to very premature infants (born ? 28 weeks of gestation) and particularly for those with a previous history of respiratory immaturity. Nonetheless, preterm infants should not be withdrawn from the immunisation scheme because the benefit of vaccination outweighs the risk of apnoea. |
| II/0045 | Change(s) to the manufacturing process for the active substance Medical                                                                                                                                                                            | 15/11/2007    | 21/11/2007        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

<div style=\"page-break-after: always\"></div>

| IA/0046   | IA_04_Change in name and/or address of a manuf. of the active substance (no Ph. Eur. cert. avail.)                                                                                                                                               | 28/08/2007    | n/a        | Annex II                      |                                                                                                                                                                                                                                                           |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------|------------|-------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0044   | IA_16_b_Submission of new TSE certificate relating to active substance - other substances                                                                                                                                                        | 19/07/2007    | n/a        |                               | authorised                                                                                                                                                                                                                                                |
| II/0039   | Change(s) to the test method(s) and/or specifications for the active substance                                                                                                                                                                   | 26/04/2007    | 10/05/2007 |                               |                                                                                                                                                                                                                                                           |
| II/0041   | To update section 4.4 of the SPC to add a warning related to immunisation in infants or children with severe neurological disorders. The PL was updated accordingly. Update of Summary of Product Characteristics, Labelling and Package Leaflet | 22/02/2007    | 03/05/2007 | SmPC, Labelling and PL longer | Further to a review of the literature, the warning section was updated to reinforce that as for any vaccination, the risk-benefit of administering Infanrix Penta should be weighed carefully if the infant or child have a severe neurological disorder. |
| II/0038   | Change(s) to the manufacturing process for the active substance                                                                                                                                                                                  | 22/02/2007 no | 13/04/2007 | SmPC, Labelling and PL        |                                                                                                                                                                                                                                                           |
| II/0042   | Update of or change(s) to the pharmaceutical documentation                                                                                                                                                                                       | 22/02/2007    | 26/02/2007 |                               |                                                                                                                                                                                                                                                           |
| II/0040   | Change(s) to the manufacturing process for the finished product product                                                                                                                                                                          | 16/11/2006    | 22/11/2006 |                               |                                                                                                                                                                                                                                                           |
| X/0028    | X_01_vi_Qualitative change in declared active substance - Other                                                                                                                                                                                  | 23/06/2005    | 24/01/2006 |                               |                                                                                                                                                                                                                                                           |
| II/0033   | Change(s) to the manufacturing process for the active substance                                                                                                                                                                                  | 15/12/2005    | 21/12/2005 |                               |                                                                                                                                                                                                                                                           |

<div style=\"page-break-after: always\"></div>

| R/0032   | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                      | 13/10/2005    | 17/11/2005   | SmPC, Labelling and PL   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------|--------------|--------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0031  | Change(s) to the test method(s) and/or specifications for the active substance Change(s) to the test method(s) and/or specifications for the finished product                                                                                                                                                | 15/09/2005    | 03/10/2005   |                          | authorised                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| IB/0035  | IB_12_b_02_Change in spec. of active subst./agent in manuf. of active subst. - test parameter                                                                                                                                                                                                                | 28/09/2005    | n/a          | longer                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| II/0030  | Update of section 4.8 of the SPC to include information on limb swelling, following the assessment of the 5th-8th PSURs covering the period from 23 October 2003 to 22 October 2004. Relevant sections of the PL were updated accordingly . Update of Summary of Product Characteristics and Package Leaflet | 23/06/2005 no | 13/09/2005   | SmPC and PL              | In line with the CHMP recommendations further to the assessment of the data from the 5th-8th PSURs, the MAH applied to update the information regarding limb swelling. The new wording provided allows differentiation between the levels of severity of the swelling: ? 50 mm circumference (very common) and > 50 mm circumference (common). Furthermore 'swelling of the entire injected limb' was included as observed during post-marketing surveillance'. |
| IA/0036  | IA_25_b_01_Change to comply with Ph. - compliance with EU Ph. update - active substance                                                                                                                                                                                                                      | 05/09/2005    | n/a          |                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| IA/0034  | IA_12_a_Change in spec. of active subst./agent used in manuf. of active subst. - tightening of spec. product                                                                                                                                                                                                 | 31/08/2005    | n/a          |                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| II/0027  | Change(s) to the manufacturing process for the active substance                                                                                                                                                                                                                                              | 23/06/2005    | 30/06/2005   |                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| IA/0029  | IA_12_a_Change in spec. of active subst./agent used in manuf. of active subst. - tightening of spec.                                                                                                                                                                                                         | 07/04/2005    | n/a          |                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

<div style=\"page-break-after: always\"></div>

| N/0026   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)         | 13/12/2004   | Labelling and PL   |
|----------|----------------------------------------------------------------------------------------------------------|--------------|--------------------|
| IB/0025  | IB_38_b_Change in test procedure of finished product - minor change, biol. active subst./excipient       | 02/12/2004   | n/a                |
| II/0023  | Quality changes                                                                                          | 22/04/2004   | 10/05/2004         |
| IA/0024  | IA_05_Change in the name and/or address of a manufacturer of the finished product                        | 12/03/2004   | n/a authorised     |
| II/0022  | Change(s) to the manufacturing process for the active substance                                          | 26/02/2004   | 01/03/2004         |
| IB/0021  | IB_23_a_Change in source of excip./reagent to veg./synthetic material - biological act. subst.           | 03/12/2003   | n/a longer         |
| II/0018  | Change(s) to the test method(s) and/or specifications for the finished product                           | 20/11/2003   | 24/11/2003 no      |
| I/0019   | 12_Minor change of manufacturing process of the active substance                                         | 25/09/2003   | 03/10/2003         |
| N/0020   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) product | 06/08/2003   | Labelling and PL   |
| I/0017   | 25_Change in test procedures of the medicinal product                                                    | 26/06/2003   | 03/07/2003         |
| II/0016  | Change(s) to the test method(s) and/or specifications for the active substance Medical                   | 20/02/2003   | 10/03/2003         |
| N/0015   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)         | 19/09/2002   | PL                 |

<div style=\"page-break-after: always\"></div>

| I/0014   | 31_Change in container shape                                                                                                                         | 20/09/2002    | 27/09/2002                                                   |
|----------|------------------------------------------------------------------------------------------------------------------------------------------------------|---------------|--------------------------------------------------------------|
| II/0013  | Change(s) to the test method(s) and/or specifications for the finished product                                                                       | 30/05/2002    | 07/06/2002                                                   |
| I/0010   | 30_Change in pack size for a medicinal product                                                                                                       | 07/11/2001    | 06/02/2002 SmPC and                                          |
| I/0011   | 30_Change in pack size for a medicinal product                                                                                                       | 07/11/2001    | Labelling 06/02/2002 SmPC and authorised                     |
| I/0009   | 03_Change in the name and/or address of the marketing authorisation holder 01_Change following modification(s) of the manufacturing authorisation(s) | 05/11/2001    | Labelling 18/12/2001 SmPC, Annex II, Labelling and PL longer |
| I/0008   | 01_Change in the name of a manufacturer of the medicinal product                                                                                     | 16/11/2001 no | 28/11/2001                                                   |
| I/0012   | 01_Change in the name of a manufacturer of the medicinal product                                                                                     | 16/11/2001    | 28/11/2001                                                   |
| II/0002  | Update of or change(s) to the pharmaceutical documentation product                                                                                   | 15/11/2001    | 27/11/2001                                                   |
| II/0007  | Quality changes                                                                                                                                      | 20/09/2001    | 02/10/2001                                                   |
| II/0006  | Change(s) to the test method(s) and/or specifications for the active substance Medical                                                               | 23/08/2001    | 24/09/2001                                                   |
| I/0004   | 25_Change in test procedures of the medicinal product                                                                                                | 26/04/2001    | n/a                                                          |
| I/0005   | 20_Extension of shelf-life as foreseen at time of authorisation                                                                                      | 26/03/2001    | n/a SmPC                                                     |

<div style=\"page-break-after: always\"></div>

| 26_Changes to comply with supplements to pharmacopoeias   | 23/03/2001   | n/a   | I/0003   |
|-----------------------------------------------------------|--------------|-------|----------|
| 13_Batch size of active substance                         | 25/01/2001   | n/a   | I/0001   |

<!-- image -->